All countries
All categories
Compare
Add to selected
Share   ID: 59200:241592
Buy Solutions for Pharma Industry
0UAHGet latest price
Description

Based in Zug (Switzerland), Lallemand Pharma International (LPI) is dedicated exclusively to the clinical studies, registration, marketing and sales of pharmaceutical products based on high quality mechanical bacterial lysates produced by Lallemand.

The primary objective of LPI is to develop and sell a range of bacterial lysates (Ismigen®, Immubron®, Bromunyl®, Respibron® and Bactovax®) produced at Lallemand's Saint-Simon facility in France. The specificity of these lysates is that they are produced from a complete range of pathogenic bacteria that are inactivated through mechanical lysis. This original and unique process gives the drug a far stronger immunogenic power than other lysates currently on the market.

The company's key product - Ismigen® - is recommended in the prophylaxis and treatment of chronic and acute respiratory infections and diseases. Backed by numerous clinical trials, Ismigen® is already registered and successfully marketed in numerous countries.

Photos
  • Solutions for Pharma Industry
  • Would you like to see more pictures?

    Send inquiry
Buy solutions for pharma industry
Order
Get latest price
Or contact the seller
Try to describe briefly the essence of your question to the seller (at least 20 symbols)
Go backin section "Pharma Raw Material"
for
by the goods
Your message must contain at least 20 symbols. The message must not be more than 2000 symbols.
Obligatory field is not filled
The field is wrongly filled
The field is wrongly filled
Compare0
ClearSelected items: 0